Accounts Payable, Current in USD of Calidi Biotherapeutics, Inc. from Q4 2021 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Calidi Biotherapeutics, Inc. quarterly Accounts Payable, Current history and change rate from Q4 2021 to Q2 2023.
  • Calidi Biotherapeutics, Inc. Accounts Payable, Current for the quarter ending 30 Jun 2023 was $487K, a 1652% increase year-over-year.
Accounts Payable, Current, Quarterly (USD)
Accounts Payable, Current, YoY Quarterly Change (%)

Calidi Biotherapeutics, Inc. Quarterly Accounts Payable, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2023 $487K +$460K +1652% 30 Jun 2023 10-Q 21 Aug 2023
Q1 2023 $142K +$100K +242% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $51.1K -$12.8K -20% 31 Dec 2022 10-Q 21 Aug 2023
Q3 2022 $103K 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $27.8K 30 Jun 2022 10-Q 10 Aug 2022
Q1 2022 $41.5K 31 Mar 2022 10-Q 11 May 2022
Q4 2021 $63.8K 31 Dec 2021 10-K 31 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.